BioSpace News Archive

BioMidwest

First Omicron XE Variant in Miami-Dade Identified by AHF Partner

A sample of a new recombinant variant of SARS-CoV-2 virus, called Omicron XE, has been identified for the first time in the Miami-Dade area by a partner of AHF’s SARS-CoV-2 Genomic Sequencing Fund.

July 13, 2022
·
2 min read
High Incidence of Knee Problems Can Expect to Drive Asia Pacific Knee Replacement Implants Market Growth

The global knee replacement implants market size is expected to reach USD 17.45 Billion in 2030 and register a revenue CAGR of 5.3% over the forecast period, according to latest report by Reports and Data.

July 13, 2022
·
6 min read
Continuous Glucose Monitoring Market Size, Share, Trends, Growth, Report 2022 to 2030

The global continuous glucose monitoring market was valued at US$ 992.8 Mn in 2022.

July 13, 2022
·
5 min read
Endoscopy Devices Market Size, Share, Trends, Growth, Report 2022 to 2030

The global endoscopy devices market is expected to cross the value of US$ 42.8 Bn by the end of 2030.

July 13, 2022
·
11 min read
Microscopy Devices Market Size, Share, Growth, Report 20222 to 2030

The global microscopy devices market is expected to reach the value of US$ 12.4 billion by the end of 2030.

July 13, 2022
·
5 min read
Recto-vaginal Fistula Treatment Market a CAGR of 5.7% from 2022 to 2030

The global recto-vaginal fistula treatment market was valued at US$ 550.8 Mn in 2020.

July 13, 2022
·
11 min read
U.S. Pain Management Drugs Market Size to Surpass US$ 40.25 BN By 2030

The U.S. Pain Management Drugs market size was valued at US$ 31.52 billion in 2021 and is expected to hit US$ 40.25 billion by 2030, growing at a compound annual growth rate (CAGR) of 4.10% from 2022 to 2030.

July 13, 2022
·
7 min read
Pharm Country

Quest Diagnostics Launches Monkeypox Virus Testing

Quest Diagnostics today announced the nationwide availability* of the company’s lab-developed molecular diagnostic test to aid in the diagnosis of infection with the monkeypox virus, with plans to launch the CDC’s orthopoxvirus test in the first half of August.

July 13, 2022
·
3 min read
Business

Immunitas Therapeutics Appoints Lynette Herscha as Chief Operating Officer

Immunitas Therapeutics (“Immunitas”), a precision immunotherapy company committed to discovering and developing novel, differentiated therapeutics for patients with cancer, today announced the appointment of Lynette Herscha, J.D., as Chief Operating Officer.

July 13, 2022
·
3 min read
FDA

AVROBIO Receives Orphan Drug Designation from the U.S. Food and Drug Administration for AVR-RD-05, a Gene Therapy for Mucopolysaccharidosis Type II (MPSII) or Hunter Syndrome

AVROBIO, Inc . (Nasdaq: AVRO), a leading clinical-stage gene therapy company with a shared purpose to free people from a lifetime of genetic disease, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for AVR-RD-05.

July 13, 2022
·
7 min read